Introduction
The c-Myc oncoprotein is an important regulator of cellular proliferation that can induce both cell cycle progression and apoptosis and, when deregulated, drive cellular transformation. Regulation of these, and other, biological activities has been attributed to Myc's ability to repress and activate the expression of specific target genes (Dang, 1999; Grandori et al., 2000; Oster et al., 2002) . Indeed, many Myc-regulated genes are involved in the control of cell growth and proliferation, including the Myc-activated genes cad, odc, cyclin D2 and eIF-4E, and Myc-repressed genes gadd45a, pdgfbr, p15
INK4b and c-myc itself (Penn et al., 1990; Bello-Fernandez et al., 1993; Rosenwald et al., 1993; Miltenberger et al., 1995; Marhin et al., 1997; Bouchard et al., 1999; Perez-Roger et al., 1999; Oster et al., 2000; Staller et al., 2001) . As the full complement of Myc target genes is uncovered, the contribution of Myc to these biological processes, as well as the molecular mechanism of target gene regulation, will be revealed.
As a regulator of gene transcription, Myc is thought to induce and repress gene expression by distinct modes of action. The mechanisms of Myc transcriptional activation involves heterodimerization with Myc's partner protein Max to form a DNA binding domain that can then recognize and bind specific E-box elements associated with the target gene to activate transcription directly. Myc can activate genes through multiple regulatory events at both the level of transcriptional initiation and elongation (Cheng et al., 1999; Bouchard et al., 2001; Eberhardy and Farnham, 2001; Frank et al., 2001; Xu et al., 2001) . By contrast, Myc is believed to repress its target genes by interference with transcription factors or enhancers that are required at these promoters for gene activation. In certain instances, Myc appears to repress targets through an initiator sequence (Inr) in the core promoter, while other genes that lack Inrs are thought to be regulated through other transcriptional elements (Gartel et al., 2001; Izumi et al., 2001; Staller et al., 2001; Feng et al., 2002; Watanabe Ki et al., 2002) .
There are two functional domains within the Myc protein; the C-terminal domain (CTD) and the Nterminal domain (NTD) (Figure 1a) . The CTD contains a basic helix-loop-helix leucine zipper (bHLH-LZ) motif that is required for all known functions of the Myc protein, including the induction of apoptosis, cell cycle progression and transformation as well as the regulation of gene expression (Amati et al., 1992 (Amati et al., , 1993a Facchini et al., 1997) . The NTD of the Myc protein is also essential for all of Myc's biological activities. However, the specific regions of the NTD required for Myc function are not as well defined. The Myc NTD contains two highly conserved regions denoted as Myc box I and Myc box II (MbI and MbII, respectively). Analyses of NTD mutants suggest that MbII is essential for all Myc functions. In addition, other regions of the NTD, including MbI, have been implicated in Myc function, although the precise definition of the necessary regions remains to be resolved.
In recent years, detailed mutational analyses of the Myc NTD suggest that the biological activities and transcription regulatory functions of the Myc protein can be segregated. One study indicated that the ability to induce apoptosis could be uncoupled from the ability to drive transformation (Chang et al., 2000) . A second study suggested that apoptosis is separable from the activation of the target gene odc, and is associated with the ability to repress the endogenous target gene gadd45 (Conzen et al., 2000) . These initial structure-function studies have been instrumental in establishing the concept that the functions of the Myc oncoprotein can be distinguished by mutations within the Myc NTD (Lee et al., 1996; Xiao et al., 1998; Chang et al., 2000; Conzen et al., 2000; Hirst and Grandori, 2000) . However, these previous studies analysed only a subset of mutants on a specific set of activity assays. Analysing N-terminal domain mutants SK Oster et al on this foundation and further assess the regions of the Myc protein that are responsible for Myc's biological and molecular activities, we performed a detailed functional study of the Myc NTD. We have assayed a number of deletion and point mutations within the Myc NTD as well as c-Myc family members for a wide array of Myc functions. In particular, we focus on an analysis of MbI and MbII regions of Myc and determine the ability of the Myc molecules to induce cellular proliferation, apoptosis and transformation. In addition, we evaluate the ability of these Myc mutants to regulate endogenous gene expression. We ascertain the induction of gene expression as well as the repression of both an Inr-positive and Inr-negative Myc target gene. We show that induction of apoptosis, growth and transformation can each be separated with the use of Myc NTD mutants, although the relations between these activities are complex. Myc's ability to activate and repress gene expression can also be segregated. Interestingly, we also show that the repression of individual endogenous target genes are differentially regulated by particular Myc mutants, indicating that Myc can repress gene targets by more than one molecular mechanism.
Results

Expression of mutant Myc proteins in the HO15.19 cell system
To characterize the role of the amino terminus of the cMyc protein, we compared the ability of a number of mutant Myc proteins to induce growth, trigger apoptosis, drive transformation as well as repress or activate endogenous gene expression relative to that of wild-type Myc. This panel of mutant Myc proteins includes a number of deletions spanning the NTD as well as a series of point mutants that are located within the highly conserved Myc box regions (Figure 1 ). We chose to mutate hydrophilic residues within MbI and MbII as they may be involved in protein interactions. In addition, we focused on a particular residue within MbII (W135) that has been shown to be critical for Myc-induced transformation (Brough et al., 1995) . To investigate the nature of the role of this amino acid, we mutated it to a conserved, nonpolar or charged amino acid (W135F, W135A and W135E, respectively). We also included the Myc family members N-Myc and LMyc in our study as they are highly homologous to cMyc (39 and 33% amino-acid identity, respectively) and appear to have overlapping, although not completely, redundant functions (DePinho et al., 1987; Small et al., 1987; Birrer et al., 1988; Barrett et al., 1992; Nesbit et al., 1998; Landay et al., 2000) . For the majority of our studies, we employed the Myc-null HO15.19 cell line, which lacks endogenous expression of c-, N-and L-Myc proteins (Mateyak et al., 1997) Figure 2) . Expression of the various mutant Myc proteins was clearly observed in all cell populations except uninfected HO15.19 and HO15.19 infected with GFP alone. Moreover, densitometry revealed that the levels of Myc expression were comparable in most cases, with the exception of d106-143, dMbII and W135A mutants whose expression was 3-6 fold higher than wild-type and dMbI and W135F that were expressed three fold lower than wild-type Myc. The ectopic expression appears to be an inherent feature of each particular mutant as similar levels of expression were evident within each independent pooled population of cells generated following de novo retroviral infection and selection. The reasons for the differences in expression for these mutants remain unclear. Importantly, for this study expression levels were similar among most mutants and activity is directly comparable between wild-type and mutant Myc molecules, unless otherwise noted. Interestingly, we also observed that some of the Myc mutants showed multiple bands. These bands were observed in multiple independent immunoblot analyses of these cells and also observed in immunoblot analysis of Rat1a cells expressing the same mutants, indicating that it is a property of the mutant. Although we are unsure of the nature of these extra bands, we are presently investigating whether they may be a result of ubiquitination of these mutant proteins or represent other post-translational modifications. Expression of exogenous N-and L-Myc in HO15.19 cells infected with these constructs has been previously shown (Landay et al., 2000) and is comparable to that of wild-type c-Myc.
Growth induction by mutant Myc proteins
To assess the regions of the NTD that are important for the ability of Myc to promote cellular proliferation, we evaluated the increase in cell number of HO15.19 cells expressing various Myc mutants over time ( Figure 3 ). As expected, the control Myc-null HO15.19 and HO15.19-gfp cells slowly increased in cell number over the 6-day period of analysis in a manner that is consistent with published results (Mateyak et al., 1997; Xiao et al., 1998; Landay et al., 2000) . In addition, cells expressing an amino-terminal deletion mutant, d1-200, grew similarly to these control Myc-null cells (Figure 3 ). The population-doubling times were determined to be between 43 and 59 h for these cell lines (Table 1) . By contrast, ectopic expression of wild-type Myc protein induced a significant increase in cell number over time (Figure 3 ) with a population doubling time of 16 h ( Time ( d104-136 and d106-143) . The analysis of the growth of these cell lines was also extended beyond 6 days to compare the cell densities achieved upon confluence. Interestingly, MycS, W135E, L-Myc and dMbII were able to grow to the same cell density as wild-type expressing cultures over an extended period (data not shown). d106-143, d104-136, d1-200 and Mycnull cells did not reach a cell density comparable with wild-type Myc despite analysis for up to 2 weeks (data not shown). Interestingly, W135A and W135F were able to induce growth to a similar extent as wild-type Myc, while W135E, a nonconservative mutation at the same residue, induced a slower growth phenotype. Thus, ectopic expression of these Myc mutants results in reconstituted cells with four distinct growth rates that can be visualized by monitoring the increase in cell number over time ( Figure 3 ) and further delineated on the basis of measured doubling times (Table 1) .
Induction of apoptosis by mutant Myc proteins
The ability of Myc mutant proteins to potentiate apoptosis following serum withdrawal in the HO15.19 cell system was investigated. Results are presented relative to the amount of apoptosis detected in the HO15.19-myc cell line ( Figure 4 ). Figure 4 ) and this degree of apoptosis did not change with continued serum withdrawal up to 96 h (data not shown). While the majority of these proteins had expression levels equal to, or greater than, that of wild-type Myc, W135F did not (Figure 2 ), leading to the possibility that the decrease in apoptosis observed for this mutant is a result of decreased expression levels, although this decrease did not affect growth potential (see Figure 3 ).
Induction of transformation by mutant Myc proteins
To determine whether there is an association between cellular transformation and other Myc activities, we assessed the transformation potential of many of the Myc mutants, including those that we determined to be deficient in Myc-induced proliferation and/or apoptosis. We took advantage of the Rat1a cell line for these experiments, which can be transformed by wild-type Myc alone (Small et al., 1987; Stone et al., 1987; Lewis et al., 1997; Shim et al., 1997; Conzen et al., 2000) and compared the ability of mutant Myc proteins to transform these cells. Rat1a cells were infected with retrovirus containing wild-type or mutant myc cDNAs. Infected cells were sorted by FACS using GFP as a selectable marker and pooled. The level of Myc expression in these cell lines was assessed (data not shown), and shown to be similar to the levels observed in the HO15.19 cells (Figure 2 ). Transformation of these cells was assessed by colony formation in soft agar. As expected, we observed that wild-type Myc was able to induce contact independent growth in these cells. Several mutants were unable to induce Rat1a colony growth, including d104-136, d106-143, dMbII and W135E. All other mutants tested were able to induce colony formation similar to wild-type Myc ( Figure 5 ).
Activation and repression of endogenous targets by mutant Myc proteins
To assess the capability of each Myc mutant to regulate gene expression, we examined activation of the The endogenous level of c-myc expression was measured using a probe specific for exon 1 of the cmyc gene, which remained intact after the knockout procedure in these cells (Mateyak et al., 1997) . Repression of endogenous c-myc RNA levels by many of the mutant Myc proteins was similar to that of wild-type Myc (data not shown). However, repression of endogenous c-myc levels was compromised in the L-Myc, MycS, dMbII, W135A, W135E, cultures. Interestingly, c-myc RNA levels in these mutant cell lines were still less than in the Myc-null control cells, indicating that weak repression of c-myc by these mutant proteins could still occur, but to a limited extent (Figure 6b , upper panel, compare lanes 3 and 4 with 1 and lane 9 with lanes 5 and 6).
We also investigated the levels of gadd45 expression, which was evident at basal levels in the HO15.19 and HO15.19-gfp cell lines and was repressed five-fold in HO15.19-myc cells (Figure 6b, middle panel) . Most mutant Myc proteins were able to repress gadd45 to a similar degree as wild-type Myc. However, gadd45 repression was abrogated in HO15.19 cells expressing MycS, d104-136, d106-143, W135A, W135E, W135F and d1-200. As determined with endogenous c-myc expression levels, there was a weak repression of gadd45 in these cells. Strikingly, dMbII and L-Myc, which were unable to repress endogenous c-myc RNA levels, were able to repress endogenous gadd45 levels (Figure 6b , compare c-myc and gadd45 levels in lanes 3 and 9). This observation suggests that there may be differing mechanisms of regulation for these Myc-repressed genes, which can be distinguished by the use of dMbII and L-Myc.
Discussion
In this study, we analysed the regions of the c-Myc protein necessary for the induction of cellular growth, apoptosis and transformation as well as the regulation of target gene expression. To accomplish this we tested the function of 22 Myc NTD mutants. Table 2 shows a summary of the results from these assays for the Myc mutants analysed and attests to the extreme complexity of the relations between the activities of the Myc protein.
From our analysis, we determined that induction of growth, apoptosis and transformation could each be segregated from one another by the use of specific mutant Myc proteins. We also showed that separate regions of the Myc protein regulated repression and activation of endogenous target genes. Moreover, we determined that the repression of endogenous targets, c-myc and gadd45, could be distinguished from one another and that the mechanism of repression of endogenous c-myc correlates with the induction of apoptosis. We observed that a few of the mutant Myc proteins were expressed at higher or lower levels than wild-type Myc, which appears to be an inherent overall property of each mutant. Importantly, we did not observe any correlation between low expression levels and lower protein activity or high expression levels and higher protein activity. Indeed, dMbI was expressed at lower levels than wild-type Myc, but was competent to fully reconstitute activity to the same degree as wild type. In addition, d106-143 was expressed at much higher levels than wild-type Myc, but was unable to induce activity to the same extent as wild type. The low expression level of the mutant W135F provided the only example in which assessing the effect of the mutant versus the effect of lower protein levels was difficult because of differences in protein expression.
Our mutant analysis revealed two Myc molecules (dMbII and L-Myc) that displayed a differential ability to repress endogenous target genes, while still being able to activate cad expression. Both were able to repress gadd45 RNA levels but were unable to repress c-myc. Evidence to date suggests that Myc represses gene expression by interacting with and inhibiting the function of activators and/or enhancers that induce expression of the target gene. Indeed, previous results suggest that there may be multiple mechanisms of repression by Myc. Myc can downregulate many genes by a mechanism dependent on the initiator element (Inr) in the core promoter (Li et al., 1994; Mai and Martensson, 1995; Wang et al., 1999; Park et al., 2001; Staller et al., 2001; Yang et al., 2001) . For example, Myc can interact with Miz-1 at the p15 INK4b promoter to block the induction of gene transcription (Staller et al., 2001) . However, genes such as pdgfbr and gadd45, which lack Inr sequences, can also be repressed by Myc, indicating that regulation must be occurring through other elements. Indeed, Myc is thought to interact with NF-Y at the pdgfbr promoter for repression of gene transcription (Izumi et al., 2001) . Further evidence to support the concept that Myc can repress by multiple mechanisms stems from our previous data using a genetic approach. By somatic cell hybridization, we showed that distinct mechanisms underlie Myc negative regulation of c-myc and pdgfbr gene expression . Indeed, the c-myc promoter is Inr-positive while pdgfbr is Inr-negative, suggesting that the presence of an Inr may be the fundamental difference between these mechanisms of repression. Interestingly, gadd45 also lacks an Inr in its promoter region and the proximal promoter elements in gadd45 are very similar to those in pdgfbr (D Lovejoy, DM and LZP, unpublished results), further suggesting that these Inr-negative genes may be regulated by a common mechanism. Our Analysing N-terminal domain mutants SK Oster et al characterization of specific Myc molecules (dMbII and L-Myc) that show a differential ability to repress endogenous gene targets will serve as valuable experimental tools to distinguish the repression mechanism used to regulate specific target genes and to further investigate the key protein-protein interactions essential for Myc repression of gene transcription. In this study, we also show that the ability of Myc to induce apoptosis in response to serum withdrawal segregates with one mechanism of Myc repression of gene transcription but not the other. A correlation between apoptosis and transcriptional repression was observed in a recent publication in which the Myc mutant d106-143 was unable to repress gadd45 or induce apoptosis in response to serum withdrawal (Conzen et al., 2000) . Indeed, in our study we observed similar results for the d106-143 Myc mutant. However, with further analysis of additional Myc mutants, we show that gadd45 and c-myc repression mechanisms can be separated, and that induction of apoptosis positively correlates with the mechanism of c-myc repression and not the mechanism of gadd45 repression. In our study, in all cases in which a mutant Myc protein was unable to fully repress the expression of c-myc, it was also unable to induce apoptosis to the same extent as wild-type Myc (Table 2 ). This association did not extend to the repression of gadd45, since both L-Myc and dMbII were able to repress gadd45 expression but unable to induce apoptosis in response to serum withdrawal to the same extent as wild-type Myc. Intriguingly, activation of the target gene cad did not seem to be important for induction of apoptosis by Myc. It has been shown that there are different regions of the Myc protein that are responsible for Myc-induced apoptosis in response to different apoptotic agonists and these regions corresponded to regions important for differential regulation of target genes (Nesbit et al., 2000) . In the light of our results it would be very interesting to assess whether regions responsible for inducing apoptosis in response to these different apoptotic agonists correlated with particular mechanisms of repression or activation.
Surprisingly, most Myc proteins were able to induce activation of the target gene cad to the same extent as wild-type Myc. Two exceptions include d104-136 and d106-143 (Table 2) . These results were also observed upon the examination of three other Myc-activated targets in this cell system (data not shown). The observed decrease in the ability of d106-143 to activate endogenous gene expression contradicts previously published results using transient transfection assays (Kato et al., 1990; Lee et al., 1996) . In these studies, Myc activation was investigated with the use of reporter plasmids under the control of synthetic promoters that contained multiple E-box elements upstream of a reporter gene or with Myc-Gal4-DBD fusion proteins and reporter constructs containing Gal4 binding sites in the promoter region. Using this approach d106-143 was able to activate these reporter genes (Kato et al., 1990; Lee et al., 1996) . This could be a consequence of high protein expression levels due to the transient transfection procedure or the nonphysiological reporter genes analysed. In our investigation this mutant is less efficient 
+=can potentiate activity to a similar extent as wild type, +/À=cannot potentiate activity to the same extent as wild type, À=does not potentiate activity, na=not applicable, nd=not done in the activation of endogenous target genes. This is supported by Conzen et al. (2000) , who observed reduced activation of endogenous odc by d106-143 in Rat1a cells. This argues that gene regulation by Myc should be measured using endogenous targets in the context of its native chromatin architecture. The concept that Myc regulation of endogenous gene transcription is highly dependent upon the formation of higher order complexes is supported by our results. Interestingly, we show that those mutants that were compromised for Myc activity usually did not lead to full loss of function, but rather displayed an intermediate phenotype. An intermediate level of activity by Myc mutants has also been observed in other studies and across multiple cell systems (Stone et al., 1987; Lee et al., 1996; Chang et al., 2000; Conzen et al., 2000; Hirst and Grandori, 2000; Kuttler et al., 2001) . We suggest these mutations, either through modification of protein structure or stability, likely change the dynamics of protein-protein interactions that occur at the level of the promoter so that gene regulation is not as robust as that with wild-type Myc. These mutations may weaken the interactions at target gene promoters without completely abolishing them. This idea is further supported by the analysis of point mutations at a tryptophan residue within MbII (W135). When mutated to a conservative residue (phenylalanine) or a nonpolar residue (alanine) there was less impact in Myc activity than when W135 was mutated to a nonconservative charged amino acid (glutamic acid) that might interfere more strongly with protein interactions. The intermediate regulation of gene expression seen here and in other systems likely explains the intermediate activities of many mutants consistently observed by ourselves and others.
To determine which biological activities of Myc correlate with the ability to induce transformation, we took advantage of the Rat1a cell line that can be transformed by Myc alone. In this system four of the mutants assessed were unable to induce colony growth dMbII and W135E) . These four mutant proteins were also unable to drive growth, induce apoptosis or repress c-myc to the same extent as wild type, indicating that some or all of these activities may be important for transformation. However, two other Myc molecules, L-Myc and MycS, deficient in growth, apoptosis and repression of c-myc, were able to induce transformation of Rat1a cells. This implies that the process of transformation by Myc is complex and does not strictly correlate with any one of Myc's biological activities.
It is interesting to note that all of the point mutations within MbI, as well as the MbI deletion mutation, displayed the same activities as wild-type Myc. Previous investigations of mutations within MbI have implicated this region of the Myc NTD in various functions of cMyc, including apoptosis, activation of target genes and transformation (Chang et al., 2000; Conzen et al., 2000) . Our results indicate that MbI is not critical for these Myc functions in this system. The MycS isoform is missing the first 100 amino acids of c-Myc, including the highly conserved MbI region.
MycS was originally reported to induce apoptosis, growth and transformation of Rat1a cells and repress reporter gene expression, but not to activate reporter gene expression (Xiao et al., 1998) . A subsequent report indicated that MycS was not able to induce apoptosis or growth to the same extent as wild type, and was a weak repressor and activator of endogenous gene expression (Hirst and Grandori, 2000) . Our own studies suggest that MycS cannot drive growth or induce apoptosis as well as wild-type Myc. However, we see that MycS is able to activate endogenous cad gene expression, but is unable to repress target gene expression to the same extent as wild type (Table 2) .
In this study, we also assessed the functions of the Myc family members N-Myc and L-Myc. Our results support the concept that N-Myc and c-Myc are functionally equivalent while L-Myc is not (DePinho et al., 1987; Small et al., 1987; Birrer et al., 1988; Barrett et al., 1992; Nesbit et al., 1998; Landay et al., 2000) . We demonstrate that L-myc is deficient in growth, apoptosis and repression of c-myc but is able to activate cad, repress gadd45 and induce transformation. L-Myc does not contain amino acids 33-41 or 72-105 of c-Myc and has many amino-acid substitutions within the NTD, which likely account for the differences in activity as compared to c-Myc. Interestingly, we also show that MycS, which is missing amino acids 1-100 of c-Myc, functions similarly to L-Myc in most assays with the exception of gadd45 repression, which is functional with L-Myc but lost with MycS (Xiao et al., 1998; Hirst and Grandori, 2000) . This suggests that residues within 1-32 or 42-71 may encode regions important for Myc repression of gadd45. Indeed L-Myc and the dMbII cMyc mutant differentially repress specific targets in a similar manner, yet L-Myc has an intact MbII region. This further strengthens the concept that Myc repression involves at least one additional region of the Myc NTD as well as the MbII domain. Clearly, the differences in L-Myc versus c-and N-Myc function would provide an interesting avenue for further investigation.
In this report, we analyse a large number of Myc mutants as well as a wide variety of Myc activities to provide a comprehensive analysis that enables direct comparison of Myc structure and function in one cell type. We show that the activities of Myc can be segregated from one another and further suggest that mechanisms of repression can be distinguished with the use of specific mutants.
Materials and methods
Cell culture
Parental TGR-1 rat fibroblasts, Myc-null HO15.19 rat fibroblasts, HO15.19 cells infected with gfp vector alone (HO15.19-gfp) and HO151.9 cells infected with gfp-myc retrovirus (HO15.19-myc) were described previously . They were maintained in 10% calf serumDulbecco's modified Eagle's medium-H21 (DMEM H21) (Gibco). The medium was supplemented with 100 mg of penicillin per ml and 100 mg of streptomycin sulfate per ml.
Rat1a cells were maintained in 10% fetal bovine serum-DMEM H21 supplemented with 100 mg of penicillin per ml and 100 mg of streptomycin sulfate per ml. The Pheonix Eco retroviral packaging cell line (American Type Culture Collection) was maintained in 10% fetal bovine serum (FBS)-DMEM H21 supplemented with 100 mg of penicillin per ml and 100 mg of streptomycin sulfate per ml.
Constructs
All mutant Myc constructs were cloned into the pBabeMNiresGFP retroviral vector (a kind gift from Gary Nolan) (Hitoshi et al., 1998; Nolan and Shatzman, 1998) . The wild-type human c-myc -2 cDNA was used as a template to produce point mutants using the Quickchange site-directed mutagenesis kit (Stratagene). Primers used to generate these mutants are as follows (mutant codons are highlighted in bold italics): D48A forward: CGGCGCCCAGCGAGGC-TATCTGGAAGAAATTC, D48A reverse: GAATTTCTTC-CAGATAGCCTCGCTGGGCGCCG; K51A forward: GCG-AGGATATCTGGGCGAAATTCGAGCTGCTGC, K51A reverse: GCAGCAGCTCGAATTTCGCCCAGATATCCTC-GC; K52A forward: GAGGATATCTGGAAGGCATTC-GAGCTGCT GCCCAC, K52A reverse: GTGGGCAGCAG-CTCGAA TGC CTTCCAGATATCCTC; L55A forward: GGAAGAAATTCGAGGCGCTGCCCACCCCG, L55A reverse:
CGGGGTGGGCAGCGCCTCGAATTTCTTCC; I130E forward: CTTCATCAAAAACATCATCGAGCAG-GACTGTAT, I130E reverse: ATACAGTCCTGCTCGAT-GATGTTTTTGATGAAG; Q131A forward: CATCATC-ATCGCGGACTGTATGTGGAGCGGC, Q131A reverse: GCCGCTCCACATACAGTCCGCGATGATGATG; C133A forward: CATCATCATCCAGGACGCTATGTGGAGCG-GCTTC, C133A reverse: GAAGCCGCTCCACATAGCGT-CCTGGATGATGATG; W135A forward: ATCATCATC-CAGGACTGTATGGCGAGCGGCTTCTC, W135A reverse: GAGAAGCCGCTCGCCATACAGTCCTGGATGATGAT; W135E forward: CAGGACTGTATGGAAAGCGGC-TTCTCGG, W135E reverse: CCGAGAAGCCGCTTTCCA-TACAGTCCTG; W135F forward: CAGGACTGTATGTT-CAGCGGCTTCTCGG, W135F reverse: CCGAGAA GCCGCTGAACATACAGTCCTG; S136A forward: CCAG-GACTGTATGTGGGCCGGCTTCTCGG, S136A reverse: CCGAGAAGCCGGCCCACATACAGTCCTGG. The deletion of 1-200 was accomplished using PCR amplification of the wild-type Myc template with the primers: 5 0 -EcoR1: GCCGAATTCACCATGGACAGCAGCTCGCCCAAGT-CC, 3 0 -Stu1: GCCAGGCCTTTACGCACAAGAGTTCCG-TAG, which amplify only nucleotides 600-1317 of the wildtype c-myc cDNA, leading to a deletion of the first 200 amino acids. MycS was cloned by excising the first 100 amino acids from the wild-type myc cDNA cloned into the pBabeMNiresGFP vector using the PvuII restriction site in the myc cDNA and the EcoRI restriction site in the vector. The remaining cDNA was then recloned into the pBabeMNiresGFP leading to a deletion of the first 300 nucleotides. dMbI, a kind gift from Elizabeth Flinn, is a deletion of amino acids 41-66 and has been described elsewhere (Flinn et al., 1998) . The deletion constructs d109-126, d92-106, dMbII (d128-143) and d104-136 were a gift from Martin Eilers and have been described elsewhere (Philipp et al., 1994) . L-Myc, a gift from Ed Prochownik, has been previously described (Landay et al., 2000) .
Retroviral production and infection
To produce infectious replication-deficient ecotropic retroviral particles, retroviral constructs were transfected by the calcium phosphate method into the Phoenix Eco packaging cell line and viral supernatant was harvested 36-48 h later. This virus was then used immediately to infect target cells for 3-18 h in the presence of 8 mg per ml polybrene or frozen at À701C for later use. Infected cells were isolated by FACS for the GFP marker expressed from the bicistronic retroviral vector 2-3 days postinfection. GFP positive cells were isolated with a Becton Dickinson FACStarPLUS cell sorter using a Coherent Enterprise laser emitting 175 mW of light at 488 nm; GFP fluorescence (emission) was collected through a 530/30 bandpass dichroic filter. BDIS 'CELLQuest' software was used for acquisition and analysis of data. GFP-positive cells from each infection were pooled.
Immunoblot analysis
Total cellular protein was harvested from asynchronously growing cell populations using an SDS-lysis buffer and separated in a 10% polyacrylamide gel. Proteins were then transferred to a PVDF membrane (Immobilon-P, Millipore) and probed with a human Myc antibody (9E10) or an actin antibody as a loading control (Sigma). Densitometry results were obtained using ImageQuant analysis software (Molecular Dynamics).
Cellular proliferation
Cellular proliferation of HO15.19 cells infected with mutant Myc constructs was assessed by subconfluently seeding 2000 cells/well in a 24-well dish and counting the number of cells in triplicate wells over a 6-day period using a Coulter Counter. Experiments were performed between two and four times for each cell line with similar results. Calculation of population doubling time was accomplished by fitting an exponential curve to the data for a single experiment using Microsoft Excel and assessing the doubling time using the equation of the line.
Propidium iodide staining and flow cytometry HO15.19 cells expressing various Myc mutants were seeded subconfluently at 200 000 cells in a 10 cm tissue culture dish in duplicate. After 24 h, the medium was replaced with either medium containing 10% calf serum or that containing 0.03% calf serum. Cells were harvested and fixed in 80% ethanol 48 h later. They were then stained with propidium iodide and analysed using a FACScalibur cytometer (Becton Dickinson, San Jose, CA, USA) to determine the amount of apoptotic cells that were present in a pre-G1 peak. Apoptosis in response to serum withdrawal has been assessed two-six times for each cell line.
Colony growth in soft agar
To investigate growth in soft agar, 250 cells were plated in 10% FBS-DMEM H21+0.3% noble agar in 30-mm Petri dishes containing an agar plug coating the bottom of the dish. Cell growth media (10% FBS-DMEM H21) was added to each plate once a week. The number of colonies measuring between 0.5 and 1.5 mm was assessed 4 weeks later. Experiments were repeated three-six times for each cell line and within each experiment five plates for each cell line were assessed.
RNase protection assay (RPA)
RNase protection assays were conducted as previously described (Penn et al., 1990; Miltenberger et al., 1995; Marhin et al., 1997) . Briefly, RNA harvested from asynchronously growing HO15.19 cell cultures (Trizol, Gibco) was hybridized to a radioactive 32 P-labelled riboprobe specific for the gene of interest (c-myc exon 1, gadd45, cad or gapdh). RNases were added to digest single-stranded RNA molecules. Protected double-stranded RNA molecules were then electrophoresed in a 6% polyacrylamide denaturing gel and visualized by autoradiography. Expression levels of cad, c-myc exon1 or gadd45 were determined between two and six times with independently prepared RNA samples. Densitometry results were obtained using ImageQuant analysis software (Molecular Dynamics) on results obtained from a Phosphorimager screen.
